Most not long ago, it's been identified that conolidine and the above mentioned derivatives act within the atypical chemokine receptor three (ACKR3. Expressed in identical parts as classical opioid receptors, it binds to some big selection of endogenous opioids. Unlike most opioid receptors, this receptor acts for a scavenger and does not activate